banner2

Getting started
Molecular Formula C44H69NO12

Molecular Formula C44H69NO12 - China Factory, Suppliers, Manufacturers

Molecular Formula C44H69NO12, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Tacrolimus CAS 104987-11-3 — Tacrolimus FK-506 Fujimycin CAS 104987-11-3 API Factory High Purity
Read More

Tris Acetate CAS 6850-28-8 — Tris Acetate CAS 6850-28-8 Purity >99.0% (Titration) Biological Buffer Molecular Biology Grade Factory

Sodium Citrate Dihydrate CAS 6132-04-3 Purity 99.0 Titration by HClO4 Factory Hot Selling Ruifu Chemical www.ruifuchem.com — Sodium Citrate Dihydrate CAS 6132-04-3 Purity >99.5% (Titration) Ultrapure For Molecular Biology Factory

CAS RN 79803-73-9 MOPSO Sodium Salt — MOPSO Sodium Salt CAS 79803-73-9 Purity >99.0% (Titration) Biological Buffer Molecular Biology Grade Factory

CAS RN 66992-27-6 BES Sodium Salt — BES Sodium Salt CAS 66992-27-6 Purity >99.0% (Titration) Biological Buffer Molecular Biology Grade Factory

Sodium Acetate CAS 127-09-3 — Sodium Acetate CAS 127-09-3 Purity >99.5% (Titration) Biological Buffer Molecular Biology Grade Factory

Potassium Phosphate Monobasic CAS 7778-77-0 PURITY — Potassium Phosphate Monobasic CAS 7778-77-0 Purity >99.5% (Titration) Molecular Biology Grade Factory

banner1

Top Selling Products

Related Blog
Reviews

The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) -Shanghai Ruifu Chemical Co., Ltd. will attend with customers.

Shanghai Ruifu Chemical Co., Ltd. will attend the The 87th China International Pharmaceutical Apis/Intermediates/Packaging/Equipment Fair (API China) with customers. The 87th China International ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, ...

2022.09.27 20:54:08
2022.09.03 06:02:13
2022.06.21 21:10:30
2022.04.11 11:06:32
2022.01.31 00:10:12
2021.10.21 15:32:28

related search